Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a
Clinical trial NCT05548439 · COMPLETED
Trial details
- NCT number
- NCT05548439
- Sponsor
- VBI Vaccines Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2024-01-16
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.